Transcutaneous analyte sensor
The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.
1. A method for processing sensor data from a continuous glucose sensor, the method comprising:
receiving sensor data from a continuous glucose sensor, wherein the sensor data is indicative of a glucose concentration in a host; and
calibrating, using an electronic device, the sensor data based on predetermined calibration information without reference data from a reference glucose monitor, wherein the predetermined calibration information comprises predetermined sensitivity information and predetermined baseline information associated with the continuous glucose sensor, and wherein the predetermined calibration information is derived from in vivo testing of at least one other continuous glucose sensor or in vitro testing.
2. The method of claim 1 , wherein the calibrating comprises determining a conversion function for the sensor data, wherein the conversion function is based on the predetermined calibration information.
3. The method of claim 2 , further comprising converting the sensor data using the conversion function.
4. The method of claim 3 , wherein the conversion function is determined without reference data from a reference glucose monitor.
5. The method of claim 3 , wherein the conversion function is based on reference data from a reference glucose monitor and the predetermined calibration information.
6. The method of claim 5 , wherein the reference data comprises a single reference data point from the reference glucose monitor, and wherein the conversion function is based on the single reference data point and the predetermined calibration information.
7. The method of claim 1 , wherein the calibrating comprises determining a conversion function for the sensor data, and wherein the calibrating further comprises at least one of guiding or validating the conversion function based on the predetermined calibration information.
8. The method of claim 7 , comprising validating the conversion function based on the predetermined calibration information and determining an error if the validation fails.
9. The method of claim 7 , comprising validating the conversion function based on the predetermined calibration information and requesting reference data if the validation fails.
10. The method of claim 7 , comprising validating the conversion function based on the predetermined calibration information and converting the sensor data if the validation passes.
11. The method of claim 1 , wherein the predetermined sensitivity information is derived from in vitro testing.
12. The method of claim 1 , wherein the predetermined baseline information is derived from in vitro testing.
13. The method of claim 1 , wherein the predetermined sensitivity information is derived from in vivo testing of at least one other continuous glucose sensor.
14. The method of claim 1 , wherein the predetermined baseline information is derived from in vivo testing of at least one other continuous glucose sensor.
15. The method of claim 1 , wherein the reference glucose monitor is a self-monitoring blood glucose monitor.
16. The method of claim 1 , wherein the predetermined calibration information is provided in a calibration code, and wherein the calibration code is detected or received by the electronic device after sensor insertion.
17. A system for processing sensor data from a continuous glucose sensor, the system comprising:
a continuous glucose sensor configured to provide sensor data indicative of a glucose concentration in a host;
a processor module configured to calibrate the sensor data based on predetermined calibration information without reference data from a reference glucose monitor, wherein the predetermined calibration information comprises sensitivity information and baseline information associated with the continuous glucose sensor, and wherein the predetermined calibration information is derived from in vivo testing of at least one other continuous glucose sensor or in vitro testing.
18. The system of claim 17 , wherein the processor module is configured to determine a conversion function for the sensor data, wherein the conversion function is based on the predetermined calibration information.
19. The system of claim 18 , wherein the processor module is configured to convert the sensor data using the conversion function.
20. The system of claim 19 , wherein the conversion function is determined without reference data from a reference glucose monitor.
21. The system of claim 19 , wherein the conversion function is based on reference data from a reference glucose monitor and the predetermined calibration information.
22. The system of claim 21 , wherein the reference data comprises a single reference data point from the reference glucose monitor, and wherein the conversion function is based on the single reference data point and the predetermined calibration information.
23. The system of claim 17 , wherein the processor module is configured to determine a conversion function for the sensor data, and wherein the processor module is configured to guide or validate the conversion function based on the predetermined calibration information.
24. The system of claim 23 , wherein the processor module is configured to validate the conversion based on the predetermined calibration information and determine an error if the validation fails.
25. The system of claim 23 , wherein the processor module is configured to validate the conversion based on the predetermined calibration information and request reference data if the validation fails.
26. The system of claim 23 , wherein the processor module is configured to validate the conversion based on the predetermined calibration information and convert the sensor data if the validation passes.
27. The system of claim 17 , wherein the predetermined sensitivity information is derived from in vitro testing.
28. The system of claim 17 , wherein the predetermined baseline information is derived from in vitro testing.
29. The system of claim 17 , wherein the predetermined sensitivity information is derived from in vivo testing of at least one other continuous glucose sensor.
30. The system of claim 17 , wherein the predetermined baseline information is derived from in vivo testing of at least one other continuous glucose sensor.
31. The system of claim 17 , further comprising:
a transmitter unit operably coupled to the glucose sensor, the transmitter unit having a radio frequency transmitter configured to wirelessly transmit sensor data; and
a receiver unit comprising a radio frequency receiver and a display, the radio frequency receiver configured to receive the transmitted sensor data and the display configured to display information based on the transmitted sensor data.
32. The system of claim 31 , wherein the processor module is incorporated in the transmitter unit.
33. The system of claim 17 , wherein the reference glucose monitor is a self-monitoring blood glucose monitor.
34. The system of claim 17 , wherein the predetermined calibration information is provided in a calibration code, and wherein the calibration code is detected or received by the processor module after sensor insertion.